[ad_1]
“Obviously, these are very interesting results. Vaccines are up to 94.5% effective, which is really amazing, ”CNN Radio quoted Dr. Anthony Fauci, director of the National Institute of Allergic and Infectious Diseases in the United States, as saying.
In Moderna’s trial, 15,000 study participants received a placebo. Over the course of several months, 90 of these people became infected with Covid-19, and 11 of them had a more advanced medical condition.
Moderna vaccinated another 15,000 volunteers and only 5 of them were infected with Covid-19. None of these 5 cases was seriously ill.
Moderna plans to seek approval from the US Food and Drug Administration (FDA) to distribute its vaccines as soon as it has additional safety data later this month.
According to preliminary results, the BNT162 vaccine from the Pfizer and BioNTech consortium is effective in protecting patients 7 days after the second dose and 28 days after the first dose.
On November 16, Mr. Fauci said that Covid-19 vaccination in the United States could begin in the second half of December, for high-risk groups such as healthcare workers, the elderly, and people with illnesses. background. After that, mass vaccination could begin in late April 2021 and last until May-July, according to Fauci.
According to data from Johns Hopkins University, the US has so far recorded more than 11 million Covid-19 infections and more than 246,000 deaths.
[ad_2]